10-Q: Q3 2024 Earnings Report
8-K: Current report
424B5: Prospectus
FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5: Prospectus
10-Q: Q2 2024 Earnings Report
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
10-Q: Q1 2024 Earnings Report
8-K: Current report
enVVeno Medical | 4: Statement of changes in beneficial ownership of securities-Officer Alavi Hamed
enVVeno Medical | 8-K: Current report
enVVeno Medical | 10-K: FY2023 Annual Report
enVVeno Medical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(9.9%),Joseph Edelman(9.9%), etc.
enVVeno Medical | SC 13G: Statement of acquisition of beneficial ownership by individuals-Nantahala Capital Management, LLC(9.9%),Wilmot B. Harkey(9.9%), etc.
enVVeno Medical | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(9.9%),Joseph Edelman(9.9%), etc.
enVVeno Medical | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Glynn Craig
enVVeno Medical | 4: Statement of changes in beneficial ownership of securities-Director Jenusaitis Matthew
enVVeno Medical | 4: Statement of changes in beneficial ownership of securities-Chief Technology Officer Alavi Hamed
enVVeno Medical | 4: Statement of changes in beneficial ownership of securities-Officer Glickman Marc H.
enVVeno Medical | 4: Statement of changes in beneficial ownership of securities-Director Gray Robert
No Data
No Data